Data as of Sep 18, 2026 · Based on 50 AI responses from ChatGPT Search and Google AI Mode · See how Parse measures this
Your brand can be here too.
There isn’t a single digital therapeutic that the **American Diabetes Association (ADA) currently recommends as “best.”** Its 2026 standards say evidence is insufficient to recommend specific diabetes apps unless they have appropriate validation/FDA clearance, and emphasize individualized selection. [Diabetes…
There isn’t a single digital therapeutic that the American Diabetes Association (ADA) currently recommends as “best.” Its 2026 standards say evidence is insufficient to recommend specific diabetes apps unless they have appropriate validation/FDA clearance, and emphasize individualized selection.
For type 2 diabetes, the strongest-supported approach is generally a digital program that combines glucose data (often CGM), personalized education/behavioral support, and clinician or coach feedback.
If you tell me whether you want FDA-cleared treatment, A1C reduction, weight loss, CGM integration, or something covered by insurance, I can compare the leading options.
When evaluating the "best" digital therapeutic (DTx) for managing type 2 diabetes, the gold standard shifts from casual lifestyle apps to **FDA-cleared, prescription-only digital therapeutics** backed by rigorous clinical…
When evaluating the "best" digital therapeutic (DTx) for managing type 2 diabetes, the gold standard shifts from casual lifestyle apps to FDA-cleared, prescription-only digital therapeutics backed by rigorous clinical trials.
The benchmark pioneer in this specific prescription category is AspyreRx (developed by Better Therapeutics and acquired/managed via Click Therapeutics).
While prescription digital therapeutics like AspyreRx focus directly on modifying neural and behavioral pathways to lower blood sugar, broader digital management categories are also widely utilized:
Note: Because prescription digital therapeutics require a formal diagnosis and clinician oversight, availability and insurance coverage can vary.
To help narrow down what might fit your situation best, could you share:
When looking for the "best" digital therapeutic (DTx) for type 2 diabetes, the landscape is divided between **prescription digital therapeutics (PDTs)** backed by clinical trials and FDA clearance, and **consumer-facing lifestyle/tracking apps**. ### 1. Prescription Digital Therapeutics (FDA-Cleared) - **AspyreRx:**…
When looking for the "best" digital therapeutic (DTx) for type 2 diabetes, the landscape is divided between prescription digital therapeutics (PDTs) backed by clinical trials and FDA clearance, and consumer-facing lifestyle/tracking apps.
Note: The "best" choice depends on whether you need psychological/behavioral support for lifestyle change (like AspyreRx) or data-driven insulin/glucose optimization (like DreaMed).
To help narrow down what might work best, could you share:
If by **“digital therapeutic”** you mean a clinically supported app/program that helps actively manage type 2 diabetes—not just a glucose-tracking app—there isn’t one universally proven “best.” The **American Diabetes Association’s 2026 Standards of Care specifically says there isn’t enough evidence to recommend…
If by “digital therapeutic” you mean a clinically supported app/program that helps actively manage type 2 diabetes—not just a glucose-tracking app—there isn’t one universally proven “best.” The American Diabetes Association’s 2026 Standards of Care specifically says there isn’t enough evidence to recommend particular diabetes apps unless they have appropriate validation/RCT evidence or FDA clearance.
For most adults with type 2 diabetes, I’d prioritize a digital program that combines glucose data + personalized coaching + medication/behavior support, rather than an app alone. ADA guidance gives this combination a recommendation because virtual licensed coaching alongside diabetes technology can improve glycemic outcomes.
The strongest setup is generally:
If you're not on insulin, CGM-based digital programs are particularly interesting: the 2026 ADA review notes growing RCT evidence that CGM can improve A1C and time-in-range even in people with type 2 diabetes not using insulin.
If you tell me your A1C, whether you use insulin/GLP-1/metformin, and whether your priority is lowering A1C, losing weight, or reducing medications, I can narrow this down to the 2–3 best current programs for your situation and compare cost, evidence, coaching, CGM integration, and insurance coverage.
When looking for the "best" digital therapeutic (DTx) for type 2 diabetes, the choice typically comes down to **FDA-cleared prescription software** backed by clinical trials versus comprehensive **virtual care platforms** that combine apps with human coaching and connected devices. The leading options categorized by…
When looking for the "best" digital therapeutic (DTx) for type 2 diabetes, the choice typically comes down to FDA-cleared prescription software backed by clinical trials versus comprehensive virtual care platforms that combine apps with human coaching and connected devices.
The leading options categorized by their regulatory and clinical approach include:
To help narrow down which option fits your situation best, could you share:
If by **“digital therapeutic”** you mean an app/program specifically designed to improve type 2 diabetes—not simply a glucose-tracking app—there isn’t one universally “best” option. The strongest choice depends on whether your priority is **lowering A1C, weight loss, medication support, or glucose monitoring**. Based…
If by “digital therapeutic” you mean an app/program specifically designed to improve type 2 diabetes—not simply a glucose-tracking app—there isn’t one universally “best” option. The strongest choice depends on whether your priority is lowering A1C, weight loss, medication support, or glucose monitoring.
Based on the current 2026 American Diabetes Association Standards of Care, I’d prioritize a program that combines digital tracking + individualized coaching/diabetes education + communication with a clinical team. The ADA specifically recommends considering technology combined with online/virtual coaching to improve glycemic outcomes.
One important distinction: digital therapeutics shouldn't replace evidence-based diabetes medication when medication is indicated. For type 2 diabetes, the 2026 ADA guidance emphasizes choosing medications based on cardiovascular, kidney, weight, hypoglycemia, cost, and other individual factors; GLP-1–based therapy is preferred to insulin for initial/add-on treatment in many people without severe hyperglycemia.
If you tell me (1) your approximate A1C, (2) whether you take insulin/other diabetes medication, (3) whether weight loss is a goal, and (4) whether insurance coverage matters, I can narrow this down to the 2–3 best digital therapeutics for your situation and compare their evidence, cost, and features.
If by **“digital therapeutic”** you mean an app/program that actively helps treat type 2 diabetes—not simply a glucose-tracking app—there isn’t one universally established “best.” The strongest evidence favors **digital diabetes programs that combine behavioral coaching, diabetes self-management education, glucose…
If by “digital therapeutic” you mean an app/program that actively helps treat type 2 diabetes—not simply a glucose-tracking app—there isn’t one universally established “best.” The strongest evidence favors digital diabetes programs that combine behavioral coaching, diabetes self-management education, glucose data, and clinician involvement rather than an app alone. The 2026 ADA Standards specifically recommend considering technology combined with online/virtual licensed coaching to improve glycemic outcomes.
For a typical adult with type 2 diabetes, I would put Omada Health among the first programs to evaluate because its model combines digital behavior change with human coaching and, depending on the program, connected glucose/weight data and clinical support. That combination aligns well with what current evidence suggests works best.
What I would prioritize:
Many products marketed as “digital therapeutics” aren't actually FDA-authorized therapeutics. The term has a specific meaning: FDA-authorized/cleared software intended to treat or manage a medical condition. The broader category of diabetes apps and virtual-care programs is much larger.
Also, digital therapy should supplement rather than replace medical care. Current ADA guidance emphasizes combining digital tools with individualized education, feedback, and clinical support.
Bottom line: If I were choosing today, I'd favor a clinician/coaching-supported digital diabetes program such as Omada over a standalone diabetes app, but the best option depends heavily on your insurance, A1C, medications, weight goals, whether you use insulin, and whether you want CGM integration.
If you tell me your insurance (e.g., Medicare, employer plan, or self-pay), whether you use insulin, and your main goal (lower A1C, weight loss, reducing medications, etc.), I can compare the top 5 options available in the U.S. in 2026 by clinical evidence, cost, CGM support, and insurance coverage.
When evaluating digital therapeutics (DTx) and digital health tools for managing type 2 diabetes, there isn't a single "best" option for everyone, as the right tool depends entirely on whether you need **prescription behavioral therapy**, **remote clinical coaching** , or **continuous glucose tracking**. The landscape…
When evaluating digital therapeutics (DTx) and digital health tools for managing type 2 diabetes, there isn't a single "best" option for everyone, as the right tool depends entirely on whether you need prescription behavioral therapy, remote clinical coaching , or continuous glucose tracking.
The landscape is generally divided into regulated prescription digital therapeutics and comprehensive virtual care platforms:
To help narrow down which digital tool or category fits your situation best, tell me:
If by **“digital therapeutic”** you mean a clinically validated digital program intended to *treat* type 2 diabetes—not just a glucose-tracking app—there isn't one universal winner. My pick depends on what you want the therapy to accomplish. ### My shortlist - **Best overall for glucose management + coaching: Omada…
If by “digital therapeutic” you mean a clinically validated digital program intended to treat type 2 diabetes—not just a glucose-tracking app—there isn't one universal winner. My pick depends on what you want the therapy to accomplish.
The American Diabetes Association's 2026 Standards of Care specifically recommend considering technology such as diabetes apps/CGM combined with virtual licensed coaching to improve glycemic outcomes.
Bottom line: If I were choosing today for an adult with type 2 diabetes, I'd favor a clinician-connected program with CGM and coaching over a standalone app. Among commercially available approaches, Omada is probably the best general-purpose choice, while Virta is particularly compelling if weight loss, nutrition, and reducing diabetes medications are major goals.
If you tell me your A1c, whether you use insulin, your main goal (lower A1c, weight loss, medication reduction, or prevention), and whether insurance coverage matters, I can narrow this to the best 1–2 options for you.
**BlueStar by Welldoc** and **AspyreRx by Better Therapeutics** are widely recognized as leading prescription digital therapeutics (PDTs) for managing type 2 diabetes, each serving slightly different clinical needs.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11378137/)…
BlueStar by Welldoc and AspyreRx by Better Therapeutics are widely recognized as leading prescription digital therapeutics (PDTs) for managing type 2 diabetes, each serving slightly different clinical needs.
Because digital therapeutics (DTx) require a doctor’s prescription and act as medical interventions, the "best" option depends on whether your primary goal is lifestyle modification with glycemic tracking or cognitive behavioral therapy for chronic condition distress.
Leading Prescription Digital Therapeutics for Type 2 Diabetes
Comparison of Top Options
| Therapeutic | Primary Focus | Regulatory Status | Best For |
|---|---|---|---|
| BlueStar | Blood glucose tracking & lifestyle coaching | FDA-cleared (Prescription) | All-around daily tracking and real-time coaching |
| AspyreRx | Cognitive behavioral therapy (CBT) | FDA-authorized (Prescription) | Overcoming psychological barriers and habit loops |
| Insulia | Basal insulin dose titration | FDA-cleared (Prescription) | Patients needing structured help with insulin adjustments |
If you'd like, let me know:
I can help you narrow down which option aligns best with your current treatment plan.